Analysis of three models to predict pathohistology in patients undergoing postchemotherapy RPLND for (pcRPLND) advanced nonseminomatous germ cell tumors (NSGCT).

Heidenreich, A; Paffenholz, P; Pfister, D; Hellmich, M; Albers, P; Hiester, A; Nini, A; Nestler, T

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (15):